University Hospital Tübingen at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University Hospital Tübingen takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions cover the principles of therapeutic cancer vaccination, brain tumours and immune responses in melanoma. It presents findings linking antibody responses against melanocytic differentiation antigens to benefit from immune checkpoint blockade in melanoma.

OrganizationESMO 2026 Attendance
medizin.uni-tuebingen.de
Cancer centre & hospital
Teaching hospital of the University of Tübingen in Tübingen, Germany, with a comprehensive cancer centre.
Chair
Sun Oct 25
08:30–10:00
All about cancer vaccines
with National Cancer Centre Singapore
Talk
Sun Oct 25
08:30–08:45
Principles of therapeutic cancer vaccination
All about cancer vaccines
Abstract
Sun Oct 25
11:23–11:35
Invited Discussant 692O, 693O and 694O
Proffered paper: CNS tumours
Sarcoma, CNS, head & neck and rare cancers
Abstract
Mon Oct 26
10:25–10:30
4251RO - Humoral immunity against melanocytic differentiation antigens associates with benefit from immune checkpoint blockade in melanoma
Rapid oral 2: Basic science and translational research
Biomarkers & precision oncology

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University Hospital Tübingen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction